Securities code: 300261 securities abbreviation: Aba Chemicals Corporation(300261) Announcement No.: 2022-008 Aba Chemicals Corporation(300261)
Announcement on abnormal fluctuations in stock trading
The company and all members of the board of directors guarantee that the information disclosed is true, accurate and complete without false records, misleading statements or major omissions.
1、 Abnormal fluctuations in stock trading
Aba Chemicals Corporation(300261) (hereinafter referred to as "the company") has accumulated more than 30% of the deviation value of the closing price decline for two consecutive trading days on February 7 and February 8, 2022. According to the relevant regulations of Shenzhen Stock Exchange, it belongs to the situation of abnormal fluctuation of stock trading. The company reminds investors to pay attention to investment risks, make rational decisions and invest prudently.
2、 The company pays attention to and verifies relevant information
In view of the abnormal fluctuation of the company's shares, the board of directors of the company verified the controlling shareholders, shareholders holding more than 5% shares, all directors, supervisors and senior managers of the company through telephone and communication. The relevant information is explained as follows:
1. Recently, the company's business situation and internal and external business environment have not changed significantly.
2. As of the date of this announcement, the company has no business contact and cooperation with Pfizer, has not signed a cooperation agreement with Pfizer, has not supplied carlon anhydride products to Pfizer, and Pfizer has not provided the company with any quality standards for the purchase of covid-19 oral front-end raw materials, Moreover, the company's customers refused to provide the end use of the purchased company's carbonic anhydride and its derivatives. The company could not determine whether the produced carbonic anhydride products met the needs of Pfizer products, nor did it conduct relevant technical verification, and could not determine whether the carbonic anhydride products produced by the company were or could become Pfizer covid-19 oral drug intermediates.
3. As of December 31, 2021, the company's sales revenue of carbonic anhydride and its derivatives in 2021 was 27.073 million yuan (excluding tax), accounting for about 1% - 2% of the company's total operating revenue in 2021, which is relatively small, and is not expected to have a significant impact on the company's performance in 2021. As of December 31, 2021, the total amount of orders on hand for carbonic anhydride and its derivatives was 63.5408 million yuan (excluding tax).
4. The trading of the company's shares resumed on February 7, 2022. Before the resumption, the company's dynamic P / E ratio was 130.93. As of the closing on February 8, 2022, the company's dynamic P / E ratio was 86.27. The details are as follows:
Dynamic P / E ratio range rise and fall
Securities code securities abbreviation as of February 8, 2022 (November 1, 2021 to February 8, 2022)
300261 Aba Chemicals Corporation(300261) 86.27 250.88%
002250 Lianhe Chemical Technology Co.Ltd(002250) 43.72 -9.22%
300575 Jiangsu Flag Chemical Industry Co.Ltd(300575) 27.46 17.63%
002258 Lier Chemical Co.Ltd(002258) 14.32 28.98%
002326 Zhejiang Yongtai Technology Co .Ltd(002326) 57.30 -54.49%
399102 gem comprehensive --- 9.71%
Investors are particularly reminded to pay attention to the following risks:
1) Recently, the company's share price in the secondary market fluctuates greatly. The company reminds investors to pay attention to the transaction risks in the secondary market, make prudent decisions and invest rationally.
2) Please fully understand the stock market risks and the risk factors disclosed by the company. The capital market is a market affected by many factors. The company's stock price may be affected by multiple factors such as macroeconomic situation, industrial policies, the company's production and operation, financial market liquidity, capital market atmosphere and investors' psychological expectations. Therefore, the company reminds investors to fully understand the stock market risks, the company's regular reports, abnormal trading fluctuation announcements Pay attention to the risk factors disclosed in the letter reply announcement and other announcements, pay attention to the transaction risk of the secondary market, make prudent decisions and rational investment, improve risk awareness, and avoid blindly following the trend.
5. The information disclosed by the company in the early stage does not need to be corrected or supplemented.
6. The company, its controlling shareholders and actual controllers do not have any major events that should be disclosed but have not been disclosed, nor do they have any major events in the planning stage.
7. During the period when there is no change in the company's shares, the actual controlling shareholder does not buy or sell the company's shares. 3、 Whether the company has information that should be disclosed but not disclosed
The board of directors of the company confirms that there is no undisclosed matter or planning, negotiation, intention, agreement, etc. related to the matter that should be disclosed according to the Listing Rules of GEM stocks of Shenzhen Stock Exchange; The board of directors has not been informed that the company has undisclosed information that has a great impact on the trading price of the company's shares and their derivatives that should be disclosed in accordance with the Shenzhen Stock Exchange GEM Listing Rules and other relevant provisions; The information disclosed by the company in the early stage does not need to be corrected or supplemented.
4、 Risk tips deemed necessary by the company
1. Through self-examination, the company does not violate the fair disclosure of information.
2. The company will conscientiously perform the obligation of information disclosure and do a good job of information disclosure in a timely manner in strict accordance with the provisions and requirements of relevant laws and regulations.
3. The information disclosure media designated by the company are securities times, China Securities News, securities daily and cninfo. Com. The information about the company shall be subject to the information published in the above designated media. Please invest rationally and pay attention to risks.
It is hereby announced.
Aba Chemicals Corporation(300261) board of directors
February 9, 2002
